195 related articles for article (PubMed ID: 31307888)
1. Tapping the therapeutic potential of protein tyrosine phosphatase 4A with small molecule inhibitors.
Tasker NR; Rastelli EJ; Burnett JC; Sharlow ER; Lazo JS; Wipf P
Bioorg Med Chem Lett; 2019 Aug; 29(16):2008-2015. PubMed ID: 31307888
[TBL] [Abstract][Full Text] [Related]
2. Drugging the Undruggable: Therapeutic Potential of Targeting Protein Tyrosine Phosphatases.
Zhang ZY
Acc Chem Res; 2017 Jan; 50(1):122-129. PubMed ID: 27977138
[TBL] [Abstract][Full Text] [Related]
3. Protein-tyrosine phosphatases: structure, mechanism, and inhibitor discovery.
Burke TR; Zhang ZY
Biopolymers; 1998; 47(3):225-41. PubMed ID: 9817026
[TBL] [Abstract][Full Text] [Related]
4. Targeting Tyrosine Phosphatases: Time to End the Stigma.
Stanford SM; Bottini N
Trends Pharmacol Sci; 2017 Jun; 38(6):524-540. PubMed ID: 28412041
[TBL] [Abstract][Full Text] [Related]
5. Drug discovery and protein tyrosine phosphatases.
Blaskovich MA
Curr Med Chem; 2009; 16(17):2095-176. PubMed ID: 19519384
[TBL] [Abstract][Full Text] [Related]
6. Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-tyrosine phosphatase 1B.
Andersen HS; Olsen OH; Iversen LF; Sørensen AL; Mortensen SB; Christensen MS; Branner S; Hansen TK; Lau JF; Jeppesen L; Moran EJ; Su J; Bakir F; Judge L; Shahbaz M; Collins T; Vo T; Newman MJ; Ripka WC; Møller NP
J Med Chem; 2002 Sep; 45(20):4443-59. PubMed ID: 12238924
[TBL] [Abstract][Full Text] [Related]
7. Functional interrogation and therapeutic targeting of protein tyrosine phosphatases.
Krabill AD; Zhang ZY
Biochem Soc Trans; 2021 Aug; 49(4):1723-1734. PubMed ID: 34431504
[TBL] [Abstract][Full Text] [Related]
8. Functional studies of protein tyrosine phosphatases with chemical approaches.
Zhang ZY
Biochim Biophys Acta; 2005 Dec; 1754(1-2):100-7. PubMed ID: 16226063
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the development of allosteric protein tyrosine phosphatase inhibitors for drug discovery.
Elhassan RM; Hou X; Fang H
Med Res Rev; 2022 May; 42(3):1064-1110. PubMed ID: 34791703
[TBL] [Abstract][Full Text] [Related]
10. Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase.
Lazo JS; Blanco IK; Tasker NR; Rastelli EJ; Burnett JC; Garrott SR; Hart DJ; McCloud RL; Hsu KL; Wipf P; Sharlow ER
J Pharmacol Exp Ther; 2019 Dec; 371(3):652-662. PubMed ID: 31601683
[TBL] [Abstract][Full Text] [Related]
11. Targeting protein tyrosine phosphatases for anticancer drug discovery.
Scott LM; Lawrence HR; Sebti SM; Lawrence NJ; Wu J
Curr Pharm Des; 2010 Jun; 16(16):1843-62. PubMed ID: 20337577
[TBL] [Abstract][Full Text] [Related]
12. High-throughput methods in identification of protein tyrosine phosphatase inhibitors and activators.
Mattila E; Ivaska J
Anticancer Agents Med Chem; 2011 Jan; 11(1):141-50. PubMed ID: 21288196
[TBL] [Abstract][Full Text] [Related]
13. Small molecule targeting of PTPs in cancer.
Lazo JS; McQueeney KE; Burnett JC; Wipf P; Sharlow ER
Int J Biochem Cell Biol; 2018 Mar; 96():171-181. PubMed ID: 28943273
[TBL] [Abstract][Full Text] [Related]
14. Structure-Based Virtual Screening of Protein Tyrosine Phosphatase Inhibitors: Significance, Challenges, and Solutions.
Reddy RH; Kim H; Cha S; Lee B; Kim YJ
J Microbiol Biotechnol; 2017 May; 27(5):878-895. PubMed ID: 28238001
[TBL] [Abstract][Full Text] [Related]
15. The Extended Family of Protein Tyrosine Phosphatases.
Alonso A; Nunes-Xavier CE; Bayón Y; Pulido R
Methods Mol Biol; 2016; 1447():1-23. PubMed ID: 27514797
[TBL] [Abstract][Full Text] [Related]
16. Knowledge-based characterization of similarity relationships in the human protein-tyrosine phosphatase family for rational inhibitor design.
Vidović D; Schürer SC
J Med Chem; 2009 Nov; 52(21):6649-59. PubMed ID: 19810703
[TBL] [Abstract][Full Text] [Related]
17. Monocyclic thiophenes as protein tyrosine phosphatase 1B inhibitors: capturing interactions with Asp48.
Wan ZK; Lee J; Xu W; Erbe DV; Joseph-McCarthy D; Follows BC; Zhang YL
Bioorg Med Chem Lett; 2006 Sep; 16(18):4941-5. PubMed ID: 16806920
[TBL] [Abstract][Full Text] [Related]
18. Protein tyrosine phosphatase inhibitors: a patent review (2002 - 2011).
Sobhia ME; Paul S; Shinde R; Potluri M; Gundam V; Kaur A; Haokip T
Expert Opin Ther Pat; 2012 Feb; 22(2):125-53. PubMed ID: 22332719
[TBL] [Abstract][Full Text] [Related]
19. Targeting PTPs with small molecule inhibitors in cancer treatment.
Jiang ZX; Zhang ZY
Cancer Metastasis Rev; 2008 Jun; 27(2):263-72. PubMed ID: 18259840
[TBL] [Abstract][Full Text] [Related]
20. Docking- and pharmacophore-based virtual screening for the identification of novel Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitor with a thiobarbiturate scaffold.
Zhang D; Lin Y; Chen X; Zhao W; Chen D; Gao M; Wang Q; Wang B; Huang H; Lu Y; Lu Y
Bioorg Chem; 2019 Apr; 85():229-239. PubMed ID: 30641319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
